Innotox is a type A botulinum toxin developed by the South Korean company Medytox Inc. It is the world's first liquid injectable form of botulinum Toxin type A approved by KFDA in South Korea, in 2013. Allergan, the Botox manufacturer, made an exclusive license agreement to market Innotox worldwide, excluding Korea and Japan.  It is produced in compliance with all international GRM standards and the conditions for the production of biological substances.

Read more